MYMX

Mymetics Corp.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 5/10/2017
Contact Info
  • co Mymetics S.A.
  • Biopole
  • Route de la Corniche, 4
  • Epalinges 1066
  • Switzerland

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0000927761
Fiscal Year End 12/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2836 - Biological products, except diagnostic
Incorporated In: DE, USA
Year of Inc. 1994
Employees 9 a/o Dec 31, 2016
Company Officers/Contacts
Ronald Kempers President, CEO
Sylvain Fleury CSO
Toon Stegmann Chief Scientific Officer
Carmelina Mahrer Director, Fin.
Company Directors
Ulrich Burkhard
Thomas Staehelin
Ernest M. Stern
Service Providers
Accounting/Auditing Firm
Peterson Sullivan LLP
601 Union St.
Suite 2300
Seattle, WA, 98101
United States
 
Securities Counsel Investor Relations Firm
Dynamics Group SA
Rue de Caroubiers 21
CH 1227 Carouge
Switzerland
 
Company History
  • Formerly=ICHOR Corp. until 7-01
  • Formerly=PDG Remediation, Inc. until 1-97
MYMX Security Details
Share Structure
Market Value1 $20,054,078 a/o Sep 20, 2017
Authorized Shares 1,000,000,000 a/o Mar 29, 2016
Outstanding Shares 303,757,622 a/o Nov 14, 2016
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 91,064,968 a/o Mar 29, 2016
Par Value 0.01
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 650 a/o Mar 30, 2017
Short Selling Data
Short Interest 36,824 (1,127.47%)
Aug 31, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security